BIOMAT Database Logo BIOMAT Database Logo

5-Bis(2-chloroethyl)aminouracil, a new antitumor agent. 1959

D A LYTTLE, and H G PETERING

UI MeSH Term Description Entries
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

D A LYTTLE, and H G PETERING
[5-Bis-(2-chloroethyl)-aminouracil, a new alkylating drug. Hematological effects].
June 1963, La Clinica terapeutica,
D A LYTTLE, and H G PETERING
The antitumor activity of 5-bis-2'-chlorethyl)-aminouracil (uracil mustard).
May 1960, Cancer research,
D A LYTTLE, and H G PETERING
Intracellular distribution of 5-bis(2-chloroethyl) aminouracil-2-C-14 in tissues of tumor-bearing rats.
February 1962, Cancer research,
D A LYTTLE, and H G PETERING
Inhibition of uptake of Larginine-U-C14 into nuclear proteins by 5-bis (2-chloroethyl) aminouracil.
November 1959, The Journal of pharmacology and experimental therapeutics,
D A LYTTLE, and H G PETERING
2-[N1-2-pyrimidyl-aminobenzenesulfonamido] ethyl 4-bis(2-chloroethyl) aminophenyl butyrate: a potent antitumor agent.
May 2001, Bioorganic & medicinal chemistry letters,
D A LYTTLE, and H G PETERING
[Preliminary note on the use of 5-bis-(2-chloroethyl)-aminouracil in the treatment of advanced neoplasms].
June 1963, La Clinica terapeutica,
D A LYTTLE, and H G PETERING
Potential antitumor agent dicyclohexylammonium 2-(4-N,N-bis(2-chloroethyl) amino)phenoxy)-2-methylpropionate.
April 1972, Journal of medicinal chemistry,
D A LYTTLE, and H G PETERING
Effect of 5-bis-(2 chloroethyl)-aminouracil on metabolism of amino acids in normal and precancerous rat liver.
December 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
D A LYTTLE, and H G PETERING
Pigmentation due to a new antitumor agent. Effects of topical application of BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea].
September 1966, Archives of dermatology,
D A LYTTLE, and H G PETERING
Antitumor 2-(aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines.
February 1996, Journal of medicinal chemistry,
Copied contents to your clipboard!